Autism Tied to Widespread Physical Health Comorbidity
FRIDAY, Oct. 13, 2023 (HealthDay News) -- People with autism have widespread, physical health comorbidity that spans nearly all major organ systems versus adults without autism, according to a study published online Sept. 20 in Molecular Autism.
John H. Ward, M.B.B.S., from the University of Exeter in the United Kingdom, and colleagues assessed whether people with autism experience greater levels of noncommunicable health conditions and, if so, if this is explained by differences in demographics, alcohol use, smoking, body mass index (BMI), or family history of medical conditions. The analysis included survey responses from 2,305 adults with autism and without.
The researchers found significantly elevated rates of noncommunicable conditions across all organ systems in people with autism, including gastrointestinal, neurological, endocrine, visual, ear/nose/throat, skin, liver and kidney, and hematological conditions. Ehlers-Danlos syndrome was more likely to occur among women with autism versus women without autism. Additionally, there was a higher prevalence of celiac disease among individuals with autism versus those without, when controlling for sex, ethnicity, country of residence, alcohol use, smoking, and BMI. However, when adjusting for family history, results became nonsignificant.
"Health care professionals must be made aware of the range of co-occurring physical health conditions that may be more common among autistic people," the authors write.
Related Posts
Un estudio de Pfizer encuentra un gran aumento en la inmunidad con el refuerzo contra la COVID
VIERNES, 4 de noviembre de 2022 (HealthDay News) -- Es probable que ponerse un...
50-µg mRNA-1273 Safe, Effective for Children Aged 6 to 11 Years
FRIDAY, May 13, 2022 (HealthDay News) -- Two 50-µg doses of the mRNA-1273...
Decline in Teen Binge Drinking Seen With Implementation of Recreational Cannabis
TUESDAY, June 27, 2023 (HealthDay News) -- Implementation of recreational...
Benefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
MONDAY, March 13, 2023 (HealthDay News) -- For patients with advanced renal cell...